IPCA MMF 500 Tablet
Prescription Required
Product introduction
IPCA MMF 500 Tablet belongs to a group of medicines called immunosuppressants. It is used with other medicines to prevent your body from rejecting an organ (such as a kidney, heart, or liver) after a transplant. It works by suppressing your body’s immune system so that it does not attack the new organ.
It is an immunosuppresant.
It is an immunosuppresant.
Uses of MMF Tablet
Benefits of MMF Tablet
In Prevention of organ rejection in transplant patients
IPCA MMF 500 Tablet belongs to a group of medicines known as immunosuppressive agents. It lowers your immune response and reduces the chance of your body attacking the transplanted organ. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine may be used in combination with other medicines to suppress the immune system and help your body accept the new organ.
Side effects of MMF Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of MMF
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- High blood pressure
- Decreased white blood cell count (neutrophils)
- Fungal infection
- Low blood platelets
- Anemia (low number of red blood cells)
- Skin cancer
- Bacterial infection
- Hypercholesterolemia (high cholesterol)
- Viral infection
- Electrolyte imbalance
- Gout
- Weight loss
- Tremors
- Convulsion
- Tumor
How to use MMF Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. IPCA MMF 500 Tablet is to be taken with food.
How MMF Tablet works
IPCA MMF 500 Tablet is an immunosuppressant. It reduces the action of the body's own defense system (the immune system) and prevents rejection of the transplanted organ.
Safety advice
Alcohol
SAFE
Consuming alcohol with IPCA MMF 500 Tablet does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
IPCA MMF 500 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
IPCA MMF 500 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
SAFE
IPCA MMF 500 Tablet does not usually affect your ability to drive.
Kidney
CAUTION
IPCA MMF 500 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of IPCA MMF 500 Tablet may be needed. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of IPCA MMF 500 Tablet in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
IPCA MMF 500 Tablet
₹66.96/Tablet
Cellcept 500mg Tablet
Roche Products India Pvt Ltd
₹66.56/tablet
1% cheaper
Mycept 500 Tablet
Panacea Biotec Ltd
₹60.32/tablet
10% cheaper
Immutil Tablet
La Renon Healthcare Pvt Ltd
₹74.8/tablet
12% costlier
Mofilet 500 Tablet
Emcure Pharmaceuticals Ltd
₹86.45/tablet
29% costlier
Renodapt 500 Tablet
Biocon
₹85.98/tablet
28% costlier
Quick tips
- Your doctor has prescribed IPCA MMF 500 Tablet to stop your body from rejecting a transplanted organ (e.g. kidney, heart or liver).
- It may take 6 to 12 weeks for IPCA MMF 500 Tablet to start working. Keep taking it as prescribed.
- It may cause birth defects so birth control is required in females with reproductive potential.
- It makes you more susceptible to getting infections. Avoid contact with people who have an infection. Consult your doctor immediately if you develop a sore throat, high temperature, any other signs of infections.
- Protect yourself from direct sunlight by wearing protective clothing and applying a sunscreen with a high sun protection factor (SPF).
- Take it with food to minimize possible side effects like nausea and stomach pain.
- Your doctor may get regular blood tests done to monitor the levels of blood cells in your blood. Inform your doctor if you experience symptoms such as unexplained bruising or bleeding, sore throat, mouth ulcers, or fever.
Fact Box
Chemical Class
Phthalide Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Immunosuppressant- Purine analogs
Patient concerns
User feedback
Patients taking IPCA MMF 500 Tablet
Twice A Day
69%
Once A Day
17%
Thrice A Day
13%
Four Times A *
1%
*Four Times A Day
What are you using MMF Tablet for?
Others
79%
Organ transpl*
21%
*Organ transplantation
How much was the improvement?
Poor
42%
Average
38%
Excellent
21%
What were the side-effects while using IPCA MMF 500 Tablet?
No Side Effec*
43%
Headache
29%
Abdominal pai*
14%
Nausea
14%
*No Side Effect, Abdominal pain
How do you take MMF Tablet?
With food
82%
Empty stomach
9%
With or witho*
9%
*With or without food
Please rate IPCA MMF 500 Tablet on price
Expensive
58%
Not Expensive
25%
Average
17%
FAQs
Can IPCA MMF 500 Tablet cause cancer?
IPCA MMF 500 Tablet may increase your chances of certain cancers like skin cancer and lymphoma (cancer of the lymph system). When outside, avoid unnecessary or prolonged exposure to sunlight, wear protective clothing, and apply sunscreen. Call your doctor if you experience a new skin sore or bump, a change in the size or color of a mole, a brown or black skin lesion (sore) with uneven edges or a sore whose one part does not look like the other, skin changes, sores that do not heal. Also, inform the doctor if you experience unexplained fever, tiredness that does not go away, weight loss, or pain or swelling in the neck, groin, or armpits.
Why has my doctor given me IPCA MMF 500 Tablet after I have had a kidney transplant?
IPCA MMF 500 Tablet is an immunosuppressant. IPCA MMF 500 Tablet has been prescribed to you to help your body accept the donor's kidney. It does so by working on the cells of your immune system, which fight with any foreign substance and reject its presence. This helps in making the transplanted organ more acceptable to your body.
Is IPCA MMF 500 Tablet a steroid or chemotherapy medicine? Can it cause hair loss?
IPCA MMF 500 Tablet is neither a steroid nor a chemotherapy medicine. It is an immunosuppressant which means that it acts on your immune system to suppress or weaken it so that your body does not reject the donated organ of another person. Hair loss is a common side effect of IPCA MMF 500 Tablet.
Do I need any special tests while taking IPCA MMF 500 Tablet?
Since IPCA MMF 500 Tablet can affect blood count and affect the kidneys and liver, your doctor will ask you to have a blood test before you start the treatment. Once the treatment starts, your doctor will suggest you take regular blood tests to check for any changes in the blood. These blood tests will help monitor your response to the medicine and the development of any side effects.
My doctor has asked me to stay away from a person who has chickenpox or shingles. Why?
IPCA MMF 500 Tablet is an immunosuppressant, which means that it decreases the activity of the immune system. Since your immune system is already weak, if you come in contact with a patient of chickenpox or shingles, you may develop it too. This is the reason that your doctor has advised you to be cautious. Therefore, follow your doctor’s advice and contact your doctor immediately if you get chickenpox or shingles as you may require special treatment.
What precautions should a female follow while taking IPCA MMF 500 Tablet?
Do not take IPCA MMF 500 Tablet if you are pregnant or are planning a pregnancy. There is a high risk of miscarriage (loss of the pregnancy) during the first 3 months of pregnancy. It may even cause birth defects (problems that are present at birth) in the newborn. Therefore, it is advised that you should use two acceptable forms of birth control together for 4 weeks before you start taking IPCA MMF 500 Tablet, during the treatment, and for 6 weeks after you stop taking IPCA MMF 500 Tablet. It is important to use a second form of birth control along with birth control pills as IPCA MMF 500 Tablet may decrease the effectiveness of birth control pills. Your doctor will suggest the two birth control methods that\ suit you the best.
What precautions should a male follow while taking IPCA MMF 500 Tablet?
It is recommended that either the man or her partner should use reliable contraception during treatment and for 90 days after the treatment. Men should not donate semen during the therapy or for 90 days following discontinuation of IPCA MMF 500 Tablet.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1014-15.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 973.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 943-45.
- Mycophenolate mofetil. Barnstaple, Devon: Accord-UK Ltd.; 2009 [revised 10 Apr. 2018]. [Accessed 06 Apr. 2019] (online) Available from:
- Mycophenolate mofetil. South San Francisco, California: Genentech USA, Inc.; 1995 [revised Feb. 2019]. [Accessed 17 Jun. 2019] (online) Available from:
- Mycophenolate mofetil. Grenzach-Wyhlen, Germany: Roche Pharma AG; 2018. [Accessed 17 Jun. 2019] (online) Available from:
- Central Drugs Standard Control Organisation. Mycophenolate mofetil. [Accessed 25 Jul. 2023] (online) Available from:
- Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993 Jul;56(1):75-82. [Accessed 01 Aug. 2023] (online) Available from:
- Mycophenolate mofetil. Basel, Switzerland: F. Hoffmann-La Roche Ltd.; 2021. [Accessed 25 Jul. 2023] (online) Available from:
- Cell Cept. Mycophenolate mofetil. [Accessed 25 Jul. 2023] (online) Available from:
- Mycophenolate mofetil [Prescribing Information]. Ahmedabad, India: Intas Pharmaceuticals Limited; 2023. [Accessed 25 Jul. 2023] (online) Available from:
Marketer details
Name: Ipca Laboratories Ltd
Address: 142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
Country of origin: India
Lab tests offered by us
Related/Popular tests
501 people bought this recentlyMRP
₹669.57
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me